{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:13:36Z","timestamp":1790255616568,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.vaccine.2023.03.033","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T04:07:30Z","timestamp":1679371650000},"page":"2837-2845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques"],"prefix":"10.1016","volume":"41","author":[{"given":"Jinling","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqian","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4412-8391","authenticated-orcid":false,"given":"Shengtao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1144","key":"10.1016\/j.vaccine.2023.03.033_b0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/postgradmedj-2020-138386","article-title":"SARS-CoV-2 and the pandemic of COVID-19","volume":"97","author":"Adil","year":"2021","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.vaccine.2023.03.033_b0010","doi-asserted-by":"crossref","unstructured":"Ong, S.W.X., et al., Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta). Clin Infect Dis, 2022. 75(1): p. e1128-e1136.","DOI":"10.1093\/cid\/ciab721"},{"issue":"4","key":"10.1016\/j.vaccine.2023.03.033_b0015","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/jmv.27491","article-title":"Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert!","volume":"94","author":"Gao","year":"2022","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.03.033_b0020","doi-asserted-by":"crossref","first-page":"e2313","DOI":"10.1002\/rmv.2313","article-title":"Covid-19 vaccines and variants of concern: A review","volume":"32","author":"Hadj Hassine","year":"2022","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2023.03.033_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108634","article-title":"COVID-19: A review of therapeutic strategies and vaccine candidates","volume":"222","author":"Izda","year":"2021","journal-title":"Clin Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.03.033_b0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41577-021-00578-z","article-title":"Immunological mechanisms of vaccine-induced protection against COVID-19 in humans","volume":"21","author":"Sadarangani","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.03.033_b0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1208\/s12249-020-01744-7","article-title":"The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation","volume":"21","author":"Wang","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"10.1016\/j.vaccine.2023.03.033_b0040","doi-asserted-by":"crossref","first-page":"e3949","DOI":"10.1093\/cid\/ciaa1703","article-title":"Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults","volume":"73","author":"Che","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"48","key":"10.1016\/j.vaccine.2023.03.033_b0045","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1016\/j.vaccine.2021.10.043","article-title":"Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine","volume":"39","author":"Fan","year":"2021","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2023.03.033_b0050","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1166\/jbn.2017.2474","article-title":"Microneedles-Based Transdermal Drug Delivery Systems: A Review","volume":"13","author":"Hao","year":"2017","journal-title":"J Biomed Nanotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.033_b0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/22221751.2021.2021807","article-title":"Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants","volume":"11","author":"Fan","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.03.033_b0060","first-page":"55","article-title":"Preclinical safety evaluation","volume":"383","author":"Holt","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2023.03.033_b0065","doi-asserted-by":"crossref","first-page":"e055781","DOI":"10.1136\/bmjopen-2021-055781","article-title":"Public health implications of SARS-CoV-2 variants of concern: a rapid scoping review","volume":"11","author":"Somerville","year":"2021","journal-title":"BMJ Open"},{"issue":"31","key":"10.1016\/j.vaccine.2023.03.033_b0070","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103272118","article-title":"Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys","volume":"118","author":"Irons","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10344","key":"10.1016\/j.vaccine.2023.03.033_b0075","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/S0140-6736(22)00484-6","article-title":"Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis","volume":"399","author":"Collaborators","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.03.033_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.777212","article-title":"SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines","volume":"11","author":"Singh","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.03.033_b0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41577-021-00556-5","article-title":"Will SARS-CoV-2 variants of concern affect the promise of vaccines?","volume":"21","author":"Gupta","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2023.03.033_b0090","article-title":"Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model","volume":"2","author":"Patel","year":"2021","journal-title":"Cell Rep Med"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2023.03.033_b0095","article-title":"Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo","volume":"23","author":"Yadav","year":"2021","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.03.033_b0100","doi-asserted-by":"crossref","unstructured":"Firmino-Cruz, L., et al., Intradermal Immunization of SARS-CoV-2 Original Strain Trimeric Spike Protein Associated to CpG and AddaS03 Adjuvants, but Not MPL, Provide Strong Humoral and Cellular Response in Mice. Vaccines (Basel), 2022. 10(8).","DOI":"10.3390\/vaccines10081305"},{"issue":"2","key":"10.1016\/j.vaccine.2023.03.033_b0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0192623313482208","article-title":"The placenta in toxicology. Part I: Animal models in toxicology: placental morphology and tolerance molecules in the cynomolgus monkey (Macaca fascicularis)","volume":"42","author":"Buse","year":"2014","journal-title":"Toxicol Pathol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.03.033_b0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.vascn.2010.05.007","article-title":"The minipig as a platform for new technologies in toxicology","volume":"62","author":"Forster","year":"2010","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.vaccine.2023.03.033_b0115","unstructured":"The General Principles for the Technical Review of Pre-clinical Safety Evaluation of Biological Products for Prevention (2008). ."},{"issue":"10","key":"10.1016\/j.vaccine.2023.03.033_b0120","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/cup.13742","article-title":"Intralymphatic histiocytosis in healing cellulitis: Case report and review of the literature","volume":"47","author":"Goldsmith","year":"2020","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.03.033_b0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1293\/tox.25.183","article-title":"Development of a Delayed-Type Hypersensitivity (DTH) Model in the Cynomolgus Monkey","volume":"25","author":"Bouchez","year":"2012","journal-title":"J Toxicol Pathol"},{"issue":"16","key":"10.1016\/j.vaccine.2023.03.033_b0130","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.neuron.2021.06.004","article-title":"Retinotopic organization of visual cortex in human infants","volume":"109","author":"Ellis","year":"2021","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.vaccine.2023.03.033_b0135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1517\/13543784.8.5.585","article-title":"Toxicity of hepatotoxins: new insights into mechanisms and therapy","volume":"8","author":"Wu","year":"1999","journal-title":"Expert Opin Investig Drugs"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23003171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23003171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:25:47Z","timestamp":1759404347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23003171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":27,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0264410X23003171"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}